Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy and safety of metronomic docetaxel and bevacizumab
combination in patients with pretreated, advanced small cell lung cancer.